Stock listing
2I3 Stock Price, News, Filings & Events — Champions Oncology, Inc.
Selected listing: 2I3 · TRADEGATE · EUR · DE
This page tracks Champions Oncology, Inc.'s 2I3:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 2I3:TRADEGATE. 2I3:TRADEGATE is the stock-level entry point for investors researching Champions Oncology, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Champions Oncology, Inc. (ticker: CSBR) is a public company based in the United States, specializing in oncology solutions. With a market capitalization of approximately $85.1 million, the company focuses on advancing personalized medicine for cancer treatment. Champions Oncology leverages its proprietary technology to improve patient outcomes and support drug development.
- Ticker
- 2I3:TRADEGATE
- Asset type
- Stock
- Market cap
- $68.5M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TRADEGATE
- Currency
- EUR
Champions Oncology, Inc. 2I3:TRADEGATE stock context
This page tracks Champions Oncology, Inc.'s 2I3:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 2I3:TRADEGATE. 2I3:TRADEGATE is the stock-level entry point for investors researching Champions Oncology, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Champions Oncology, Inc. (ticker: CSBR) is a public company based in the United States, specializing in oncology solutions. With a market capitalization of approximately $85.1 million, the company focuses on advancing personalized medicine for cancer treatment. Champions Oncology leverages its proprietary technology to improve patient outcomes and support drug development.
Latest news from Champions Oncology, Inc.
Champions Oncology Reports Record Annual Revenue of $59 Million
July 27, 2026
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026
July 20, 2026
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
March 30, 2026
Champions Oncology Reports Revenue of $16.6 Million
March 12, 2026
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
March 5, 2026
Champions Oncology, Inc. earnings calls
Champions Oncology, Inc. (CSBR) Q4 2026 Earnings Call
July 27, 2026 · Replay with transcript and chapters
Champions Oncology, Inc. (CSBR) Q3 2026 Earnings Call
March 12, 2026 · Replay with transcript and chapters
Champions Oncology, Inc. (CSBR) Q2 2026 Earnings Call
December 15, 2025 · Replay with transcript and chapters
Champions Oncology, Inc. (CSBR) Q1 2026 Earnings Call
September 15, 2025 · Replay with transcript and chapters
Champions Oncology, Inc. (CSBR) Q4 2025 Earnings Call
July 23, 2025 · Replay with transcript and chapters
Champions Oncology, Inc. (CSBR) Q3 2025 Earnings Call
March 11, 2025 · Replay with transcript and chapters
Research Champions Oncology, Inc.
Champions Oncology, Inc. investor report
Review AI stock analysis and investor report context for 2I3:TRADEGATE.
Champions Oncology, Inc. company profile
View the public company page for Champions Oncology, Inc. on 6ix.
Champions Oncology, Inc. news
Read company news and market updates connected to Champions Oncology, Inc..
Champions Oncology, Inc. investor events
Find investor webinars, events, and replay context for Champions Oncology, Inc..
Alternate listings
CSBR:NASDAQ
US · USD
Alternate listing for Champions Oncology, Inc.; the primary context on this page is 2I3:TRADEGATE.
A14X6S:LSX
DE · EUR
Alternate listing for Champions Oncology, Inc.; the primary context on this page is 2I3:TRADEGATE.
CSBR:BOATS
US · USD
Alternate listing for Champions Oncology, Inc.; the primary context on this page is 2I3:TRADEGATE.
2I3:GETTEX
DE · EUR
Alternate listing for Champions Oncology, Inc.; the primary context on this page is 2I3:TRADEGATE.
2I3:DUS
DE · EUR
Alternate listing for Champions Oncology, Inc.; the primary context on this page is 2I3:TRADEGATE.
2I3:FWB
DE · EUR
Alternate listing for Champions Oncology, Inc.; the primary context on this page is 2I3:TRADEGATE.
A14X6S:LS
DE · EUR
Alternate listing for Champions Oncology, Inc.; the primary context on this page is 2I3:TRADEGATE.
2I3:MUN
DE · EUR
Alternate listing for Champions Oncology, Inc.; the primary context on this page is 2I3:TRADEGATE.
2I3:SWB
DE · EUR
Alternate listing for Champions Oncology, Inc.; the primary context on this page is 2I3:TRADEGATE.